2022. Developing a Next-generation Multitudinous Epitope-based Vaccine Against Biotinidase Deficiency; An Immunoinformatics-based Approach. Journal of Pharmaceutical Negative Results. (Sep. 2022), 99–110. DOI:https://doi.org/10.47750/pnr.2022.13.S03.017.